This contract expires in 383 days (Jun 24, 2027).
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON - MODEL DEVELOPMENT AND MEDICAL COUNTER MEASURES (MCMS) FOR BSL-4 AGENTS IN NHPS.
Key Details
Description
MODEL DEVELOPMENT AND MEDICAL COUNTER MEASURES (MCMS) FOR BSL-4 AGENTS IN NHPS.
Context & Analysis
On Dec 19, 2025, Department of Health and Human Services obligated $1,610,509 to UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON for model development and medical counter measures (mcms) for bsl-4 agents in nhps.. The award is classified under NAICS 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY and issued as a cost no fee contract. Competition extent: full and open competition with 1 offer received. Performance is located in GALVESTON, TX. The contract is scheduled through Jun 24, 2027 — approximately 13 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541711 — related awards are listed below.
Contractor Information
Similar Awards
CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF
CERUS CORPORATION
$185.5M
THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF
MEDICINES COMPANY, THE
$98.1M
IGF::OT::IGF
JANSSEN VACCINES & PREVENTION B.V.
$48.9M
IGF::OT::IGF - DNAE / PATHOGEN IDENTIFICATION FROM SPECIMEN, VIA CAPTURE, EXTRACTION AND SEQUENCING (PISCES)
DNAE GROUP HOLDINGS LIMITED
$43.4M
AUTOGRAFT-SPARING PRODUCTS FOR DEFINITIVE CARE OF BURN INJURIES
AVITA MEDICAL AMERICAS, LLC
$40.8M
Stay Updated
Get notified about new opportunities matching your interests.